Showing 1-9 of 127 results

Skin cancer prevention and risk reduction | 53 min

(0 review)
88
students
0
Free

In this highly practical and engaging webinar from the MIA Nurse Webinar Series, MIA Dermatologist Dr Niamh-Anna O’Sullivan busts myths and controversies around sun...

Free

Critical questions for a melanoma pathologist | 36 min

(0 review)
97
students
0
Free

The role of pathologist in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the...

Free

Advances in skin cancer management | 21 min

(0 review)
198
students
0
Free

This presentation was recorded at the 2022 Australasian Skin Cancer Congress, organised by the Skin Cancer College Australasia. In this presentation, Surgeon A/Prof Sydney...

Free

Current management of advanced non-melanoma skin cancer | 32 min

(0 review)
201
students
0
Free

This presentation was recorded at the 2022 Australasian Skin Cancer Congress, organised by the Skin Cancer College Australasia. In this presentation, Medical Oncologist Dr...

Free

Toxicity management in melanoma | 45 min

(0 review)
307
students
0
Free

Cancer drugs have rapidly evolved in the last decade. Alongside the significant benefits are new toxicity profiles that clinicians need to be aware of...

Free

Updates in skin cancer diagnosis and management | RACGP ACCREDITED | 2 hrs

(0 review)
403
students
0
Free

In the rapidly evolving field of skin cancer medicine, it is important for GPs to be up to date with the latest developments to...

Free

Update on the adjuvant treatment of melanoma in 2021 | 13 min

(0 review)
505
students
0
Free

In this presentation, A/Prof Andrew Haydon reviews the efficacy data from 6 large-scale Phase III studies that are looking at the use of modern...

Free

Staging melanoma and bulky palpable Stage III melanoma – is surgery necessary? | 10 min

(0 review)
505
students
0
Free

In this presentation, A/Prof Sydney Ch’ng discovers the current recommendations for sentinel node biopsy and the implications of high-risk Stage II melanoma trial findings....

Free

Management of in-transit melanoma in the time of active systemic therapy | 11 min

(0 review)
505
students
0
Free

With up to 14% of patients developing in-transit disease and biologically diverse pathobiological behaviour is observed, in-transit disease is a significant clinical burden. In...

Free